Home › Companies › SOLID BIOSCIENCES INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and SOLID BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 12, 2025: 6 items on SOLID BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025: 2 elected · 4 approved.
Notable dissent: 1 other board item (20.6% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Ra Capital Management, L.P. (13D, 10.8%, as of November 6, 2026)
Explore SOLID BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are SOLID BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Alexander Cumbo | 59,114,835 | -- | -- | 3,202,457 | 6,576,490 | 95% | Elected | — |
| Elect Director: Sukumar Nagendran | 57,224,221 | -- | -- | 5,093,071 | 6,576,490 | 92% | Elected | — |
| 2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 68,872,513 | 18,770 | 2,499 | -- | -- | 99.9% | Approved | — |
| 3. An amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 120,000,000 to 240,000,000 (the "Share Increase Amendment") | 68,589,052 | 294,679 | 10,051 | -- | -- | 99.6% | Approved | — |
| 4. An amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision | 49,491,497 | 12,816,329 | 9,466 | -- | 6,576,490 | 79% | Approved | — |
| 5. Non-binding, advisory vote on the compensation paid to its named executive officers | 57,115,409 | 5,143,882 | 58,001 | -- | 6,576,490 | 92% | Approved | — |
Source: SOLID BIOSCIENCES INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
116 asset managers disclosed a vote on at least one SOLID BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Alexander Cumbo
SOLID BIOSCIENCES INC.’s own tally for this item (“Elect Director: Alexander Cumbo”): 59,114,835 for, 3,202,457 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Alexander Cumbo and Sukumar Nagendran as Class I directors to serve until the 2028 Annual Meeting of Stockholders, each director to hold office until his successor has been duly appointed and qualified.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 6,714,916 for, 197,247 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,774,326 | 0 | 0 | 0 | For |
| Vanguard | 2,196,117 | 0 | 0 | 0 | For |
| BlackRock | 951,045 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 449,300 | 0 | 0 | 0 | For |
| Equitable | 81,370 | 0 | 0 | 0 | For |
| Charles Schwab | 68,607 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 68,178 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 57,032 | Withhold |
| Goldman Sachs | 56,772 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 24,082 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 23,214 | 0 | 0 | 0 | For |
| Invesco | 22,856 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,800 | 0 | 0 | 0 | For |
| Global X | 13,208 | 0 | 0 | 0 | For |
| Northern Trust | 12,707 | 0 | 0 | 0 | For |
| Pacific Life | 12,295 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 12,140 | Withhold |
| Bridge Builder Trust | 9,693 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 9,389 | Withhold |
| Tema ETF Trust | 8,649 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 7,687 | Withhold |
| ProShares | 0 | 0 | 0 | 7,417 | Withhold |
| Voya | 5,861 | 0 | 0 | 0 | For |
| Nationwide | 4,718 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 3,588 | Withhold |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Sukumar Nagendran
SOLID BIOSCIENCES INC.’s own tally for this item (“Elect Director: Sukumar Nagendran”): 57,224,221 for, 5,093,071 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Alexander Cumbo and Sukumar Nagendran as Class I directors to serve until the 2028 Annual Meeting of Stockholders, each director to hold office until his successor has been duly appointed and qualified.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 5,627,870 for, 1,284,293 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,774,326 | 0 | 0 | 0 | For |
| Vanguard | 2,196,117 | 0 | 0 | 0 | For |
| BlackRock | 27,444 | 0 | 0 | 923,601 | Withhold |
| FRANKLIN STRATEGIC SERIES | 449,300 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 81,370 | Withhold |
| Charles Schwab | 68,607 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 68,178 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 57,032 | Withhold |
| Goldman Sachs | 56,772 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 24,082 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 23,214 | Withhold |
| Invesco | 22,856 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 17,800 | Withhold |
| Global X | 13,208 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 12,707 | Withhold |
| Pacific Life | 0 | 0 | 0 | 12,295 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 12,140 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 9,693 | Withhold |
| John Hancock | 0 | 0 | 0 | 9,389 | Withhold |
| Tema ETF Trust | 8,649 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 7,687 | Withhold |
| ProShares | 0 | 0 | 0 | 7,417 | Withhold |
| Voya | 5,861 | 0 | 0 | 0 | For |
| Nationwide | 1,354 | 0 | 0 | 3,364 | Mixed |
| DWS | 0 | 0 | 0 | 3,588 | Withhold |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: The approval of an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 120,000,000 to 240,000,000.
SOLID BIOSCIENCES INC.’s own tally for this item (“3. An amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 120,000,000 to 240,000,000 (the "Share Increase Amendment")”): 68,589,052 for, 294,679 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 120,000,000 to 240,000,000 (the "Share Increase Amendment").”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 6,912,163 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,774,326 | 0 | 0 | 0 | For |
| Vanguard | 2,196,117 | 0 | 0 | 0 | For |
| BlackRock | 951,045 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 449,300 | 0 | 0 | 0 | For |
| Equitable | 81,370 | 0 | 0 | 0 | For |
| Charles Schwab | 68,607 | 0 | 0 | 0 | For |
| Dimensional | 68,178 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 57,032 | 0 | 0 | 0 | For |
| Goldman Sachs | 56,772 | 0 | 0 | 0 | For |
| American Century | 24,082 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 23,214 | 0 | 0 | 0 | For |
| Invesco | 22,856 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,800 | 0 | 0 | 0 | For |
| Global X | 13,208 | 0 | 0 | 0 | For |
| Northern Trust | 12,707 | 0 | 0 | 0 | For |
| Pacific Life | 12,295 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,140 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,693 | 0 | 0 | 0 | For |
| John Hancock | 9,389 | 0 | 0 | 0 | For |
| Tema ETF Trust | 8,649 | 0 | 0 | 0 | For |
| Victory Capital | 7,687 | 0 | 0 | 0 | For |
| ProShares | 7,417 | 0 | 0 | 0 | For |
| Voya | 5,861 | 0 | 0 | 0 | For |
| Nationwide | 4,718 | 0 | 0 | 0 | For |
| DWS | 3,588 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
79% Approved · of votes cast
Description as filed by funds: The approval of an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan to increase the number of shares of our common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision.
SOLID BIOSCIENCES INC.’s own tally for this item (“4. An amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision”): 49,491,497 for, 12,816,329 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved an amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision.”
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 457,949 for, 6,454,214 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 2,774,326 | 0 | 0 | Against |
| Vanguard | 0 | 2,196,117 | 0 | 0 | Against |
| BlackRock | 0 | 951,045 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 449,300 | 0 | 0 | 0 | For |
| Equitable | 0 | 81,370 | 0 | 0 | Against |
| Charles Schwab | 0 | 68,607 | 0 | 0 | Against |
| Dimensional | 0 | 68,178 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 57,032 | 0 | 0 | Against |
| Goldman Sachs | 0 | 56,772 | 0 | 0 | Against |
| American Century | 0 | 24,082 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 23,214 | 0 | 0 | Against |
| Invesco | 0 | 22,856 | 0 | 0 | Against |
| Lincoln Financial | 0 | 17,800 | 0 | 0 | Against |
| Global X | 0 | 13,208 | 0 | 0 | Against |
| Northern Trust | 0 | 12,707 | 0 | 0 | Against |
| Pacific Life | 0 | 12,295 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 12,140 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 9,693 | 0 | 0 | Against |
| John Hancock | 0 | 9,389 | 0 | 0 | Against |
| Tema ETF Trust | 8,649 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 7,687 | 0 | 0 | Against |
| ProShares | 0 | 7,417 | 0 | 0 | Against |
| Voya | 0 | 5,861 | 0 | 0 | Against |
| Nationwide | 0 | 4,718 | 0 | 0 | Against |
| DWS | 0 | 3,588 | 0 | 0 | Against |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
92% Approved · of votes cast
Prior year: 98.3% for (June 7, 2024 meeting) ▼ 6.6 pts
Description as filed by funds: THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.
SOLID BIOSCIENCES INC.’s own tally for this item (“5. The non-binding, advisory vote on the compensation paid to its named executive officers”): 57,115,409 for, 5,143,882 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,774,326 | 0 | 0 | 0 | For |
| Vanguard | 2,196,117 | 0 | 0 | 0 | For |
| BlackRock | 27,444 | 923,601 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 449,300 | 0 | 0 | 0 | For |
| Equitable | 0 | 81,370 | 0 | 0 | Against |
| Charles Schwab | 0 | 68,607 | 0 | 0 | Against |
| Dimensional | 0 | 68,178 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 57,032 | 0 | 0 | Against |
| Goldman Sachs | 0 | 56,772 | 0 | 0 | Against |
| American Century | 0 | 24,082 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 23,214 | 0 | 0 | Against |
| Invesco | 0 | 22,856 | 0 | 0 | Against |
| Lincoln Financial | 17,800 | 0 | 0 | 0 | For |
| Global X | 13,208 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 12,707 | 0 | 0 | Against |
| Pacific Life | 0 | 12,295 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 12,140 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 9,693 | 0 | 0 | Against |
| John Hancock | 0 | 9,389 | 0 | 0 | Against |
| Tema ETF Trust | 8,649 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 7,687 | 0 | 0 | Against |
| ProShares | 0 | 7,417 | 0 | 0 | Against |
| Voya | 0 | 5,861 | 0 | 0 | Against |
| Nationwide | 1,354 | 3,364 | 0 | 0 | Mixed |
| DWS | 0 | 3,588 | 0 | 0 | Against |
Fund voting reports, all 37 managers: 5,494,259 for, 1,417,904 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10,795,715 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,699,484 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 6,402,653 | 0 | 0 | 0 | For |
| Commodore Capital LP | 5,825,000 | 0 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 5,034,582 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 4,587,613 | 0 | 0 | 0 | For |
| Fidelity | 2,379,453 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 1,963,128 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 1,803,336 | 0 | 0 | 0 | For |
| VR Adviser, LLC | 1,480,202 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,240,700 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 0 | 1,188,233 | 0 | 0 | Against |
| MPM BioImpact LLC | 1,185,639 | 0 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 0 | 782,558 | 0 | 0 | Against |
| BlackRock | 29,650 | 603,256 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 461,394 | 0 | 0 | 0 | For |
| Woodline Partners LP | 365,828 | 0 | 0 | 0 | For |
| Casdin Capital, LLC | 0 | 300,000 | 0 | 0 | Against |
| State Street | 223,360 | 1,627 | 0 | 0 | For |
| Citadel | 213,479 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 213,335 | 0 | 0 | 0 | For |
| Point72 | 0 | 148,075 | 0 | 0 | Against |
| APIS CAPITAL ADVISORS, LLC | 139,995 | 0 | 0 | 0 | For |
| Knott David M Jr | 0 | 132,000 | 0 | 0 | Against |
| Birchview Capital, LP | 127,217 | 0 | 0 | 0 | For |
Institutional-manager reports, all 93 managers: 51,393,069 for, 3,871,276 against. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Prior year: 100.0% for (June 7, 2024 meeting) unchanged
Description as filed by funds: The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
SOLID BIOSCIENCES INC.’s own tally for this item (“2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 68,872,513 for, 18,770 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 6,911,178 for, 985 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,774,326 | 0 | 0 | 0 | For |
| Vanguard | 2,196,117 | 0 | 0 | 0 | For |
| BlackRock | 951,045 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 449,300 | 0 | 0 | 0 | For |
| Equitable | 81,370 | 0 | 0 | 0 | For |
| Charles Schwab | 68,607 | 0 | 0 | 0 | For |
| Dimensional | 68,178 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 57,032 | 0 | 0 | 0 | For |
| Goldman Sachs | 56,772 | 0 | 0 | 0 | For |
| American Century | 24,082 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 23,214 | 0 | 0 | 0 | For |
| Invesco | 22,856 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,800 | 0 | 0 | 0 | For |
| Global X | 13,208 | 0 | 0 | 0 | For |
| Northern Trust | 12,707 | 0 | 0 | 0 | For |
| Pacific Life | 12,295 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,140 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,693 | 0 | 0 | 0 | For |
| John Hancock | 9,389 | 0 | 0 | 0 | For |
| Tema ETF Trust | 8,649 | 0 | 0 | 0 | For |
| Victory Capital | 7,687 | 0 | 0 | 0 | For |
| ProShares | 7,417 | 0 | 0 | 0 | For |
| Voya | 5,861 | 0 | 0 | 0 | For |
| Nationwide | 4,718 | 0 | 0 | 0 | For |
| DWS | 3,588 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 77,515,377 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 3.58% |
| 2 | Vanguard | 2.83% |
| 3 | BlackRock | 1.23% |
| 4 | FRANKLIN STRATEGIC SERIES | 0.58% |
| 5 | Equitable | 0.10% |
| 6 | Charles Schwab | 0.09% |
| 7 | Dimensional | 0.09% |
| 8 | BRIDGEWAY FUNDS INC | 0.07% |
| 9 | Goldman Sachs | 0.07% |
| 10 | American Century | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 13.93% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.64% |
| 3 | Siren, L.L.C. | 8.26% |
| 4 | Commodore Capital LP | 7.51% |
| 5 | Bain Capital Life Sciences Investors, LLC | 6.49% |
| 6 | RA CAPITAL MANAGEMENT, L.P. | 5.92% |
| 7 | Fidelity | 3.07% |
| 8 | Redmile Group, LLC | 2.53% |
| 9 | Nantahala Capital Management, LLC | 2.33% |
| 10 | VR Adviser, LLC | 1.91% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| RA Capital Management, L.P. | 12,036,126 | — | Schedule 13D, filed June 24, 2026 |
| Perceptive Life Sciences Master Fund Ltd. and affiliated entities | 11,934,678 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| Raymond Debbane | 10,066,682 | — | Schedule 13G, filed May 5, 2026 |
| BCLS II Investco, LP | 8,604,852 | — | Schedule 13D, filed March 10, 2026 |
| Entities affiliated with RA Capital Management, L.P. | 8,080,563 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| Entities affiliated with Bain Capital Life Sciences Investors, LLC | 8,041,572 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| Invus Public Equities, L.P. and affiliated entities | 7,415,905 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| Commodore Capital Master LP | 5,825,000 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
| Vestal Point Capital, LP | 5,815,000 | — | Schedule 13G, filed February 17, 2026 |
| Entities managed by Vestal Point Capital, LP | 4,288,850 | — | Proxy statement (DEF 14A), proxy filed April 25, 2025 |
Percentages above are of 77,515,377 shares outstanding, as reported by SOLID BIOSCIENCES INC. on its Form 10-Q dated May 12, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At SOLID BIOSCIENCES INC.'s shareholder meeting held June 12, 2025, in the 2024-2025 proxy season, 116 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 703 separate fund positions. On the most widely held item on that ballot — THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. — SOLID BIOSCIENCES INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: SOLID BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SOLID BIOSCIENCES INC.’s 10-Q dated May 12, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
SOLID BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “SOLID BIOSCIENCES (SLDB) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/solid-biosciences-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.